1. Home
  2. MELI vs SNY Comparison

MELI vs SNY Comparison

Compare MELI & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MELI
  • SNY
  • Stock Information
  • Founded
  • MELI 1999
  • SNY 1994
  • Country
  • MELI Uruguay
  • SNY France
  • Employees
  • MELI N/A
  • SNY N/A
  • Industry
  • MELI Catalog/Specialty Distribution
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • MELI Consumer Discretionary
  • SNY Health Care
  • Exchange
  • MELI Nasdaq
  • SNY Nasdaq
  • Market Cap
  • MELI 124.4B
  • SNY 116.5B
  • IPO Year
  • MELI 2007
  • SNY N/A
  • Fundamental
  • Price
  • MELI $2,512.88
  • SNY $48.71
  • Analyst Decision
  • MELI Strong Buy
  • SNY Buy
  • Analyst Count
  • MELI 15
  • SNY 2
  • Target Price
  • MELI $2,629.00
  • SNY $62.50
  • AVG Volume (30 Days)
  • MELI 365.9K
  • SNY 2.0M
  • Earning Date
  • MELI 07-31-2025
  • SNY 07-24-2025
  • Dividend Yield
  • MELI N/A
  • SNY 3.24%
  • EPS Growth
  • MELI 82.40
  • SNY 39.56
  • EPS
  • MELI 40.65
  • SNY 5.45
  • Revenue
  • MELI $22,379,000,000.00
  • SNY $48,817,552,946.00
  • Revenue This Year
  • MELI $33.81
  • SNY $3.39
  • Revenue Next Year
  • MELI $24.59
  • SNY $7.05
  • P/E Ratio
  • MELI $60.76
  • SNY $9.04
  • Revenue Growth
  • MELI 37.68
  • SNY N/A
  • 52 Week Low
  • MELI $1,563.21
  • SNY $45.80
  • 52 Week High
  • MELI $2,645.22
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • MELI 53.24
  • SNY 45.52
  • Support Level
  • MELI $2,433.66
  • SNY $47.64
  • Resistance Level
  • MELI $2,645.22
  • SNY $49.37
  • Average True Range (ATR)
  • MELI 72.13
  • SNY 0.66
  • MACD
  • MELI 0.83
  • SNY 0.16
  • Stochastic Oscillator
  • MELI 57.65
  • SNY 44.93

About MELI MercadoLibre Inc.

MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions when last reported. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Share on Social Networks: